Search

Your search keyword '"Morissens M."' showing total 93 results

Search Constraints

Start Over You searched for: Author "Morissens M." Remove constraint Author: "Morissens M."
93 results on '"Morissens M."'

Search Results

1. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)

2. Clinical outcome of COVID-19 in patients with adult congenital heart disease

6. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? : Results of a worldwide study

7. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease?: Results of a worldwide study

8. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study

9. Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

10. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

11. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

12. Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

13. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey

14. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation

15. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

16. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation

17. Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation

18. Relation between E/e' ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis

19. Relation between E/e ' ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis

21. Oral Abstract session: Pericardial diseases, masses and sources of embolism: Thursday 4 December 2014, 11:00-12:30 * Location: Agora

22. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation

26. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)

27. Oral Abstract session: Pericardial diseases, masses and sources of embolism: Thursday 4 December 2014, 11:00-12:30 * Location: Agora

28. Poster session 3: Thursday 4 December 2014, 14:00-18:00 * Location: Poster area

29. Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme

30. Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)

31. Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease

32. Transfer Learning Video Classification of Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction in Echocardiography.

33. Ventricular Angiography: A Forgotten Diagnostic Tool?

35. Major Adverse Cardiac Events After Fractional Flow Reserve, Instantaneous Wave-Free Ratio, or Angiography-Guided Revascularization in Atrial Fibrillation: A Retrospective Study.

37. Case Report: Challenges in the etiology of left ventricular aneurysm.

38. Major adverse cardiac events following FFR, iFR or angiography guided revascularization in atrial fibrillation: a retrospective study.

39. Particularities of coronary physiology in patients with atrial fibrillation: insights from combined pressure and flow indices measurements.

41. Non-invasive cardiac kinetic energy distribution: a new marker of heart failure with impaired ejection fraction (KINO-HF).

42. The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry.

43. A zoonotic cause of blood culture-negative infective endocarditis in Belgium: Case report and review of the literature on Q fever.

44. Prevalence of Left Atrial Septal Pouch Among Patients with Embolic Stroke of Undetermined Source Or Stroke of Known Etiology: a Retrospective Study.

45. Trichinella spiralis -associated myocarditis mimicking acute myocardial infarction.

46. Leadless pacemaker implantation: An unexpected complication.

47. Reliability of Fractional Flow Reserve and Instantaneous Wave-Free Ratio in Assessing Intermediate Coronary Stenosis in Patients With Atrial Fibrillation.

48. Assessment of Intracoronary Adenosine-Induced Hyperemia in Patients with Atrial Fibrillation in Comparison with Patients in Sinus Rhythm.

49. D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation.

50. Percutaneous Closure of an Iatrogenic Inlet Ventricular Septal Defect in an Atrioventricular Canal.

Catalog

Books, media, physical & digital resources